0001209191-21-042496.txt : 20210622
0001209191-21-042496.hdr.sgml : 20210622
20210622181335
ACCESSION NUMBER: 0001209191-21-042496
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210618
FILED AS OF DATE: 20210622
DATE AS OF CHANGE: 20210622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ocko Matthew
CENTRAL INDEX KEY: 0001836089
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 211036583
MAIL ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DCVC Bio, L.P.
CENTRAL INDEX KEY: 0001735069
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 211036589
BUSINESS ADDRESS:
STREET 1: 317 UNIVERSITY AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 415-840-7337
MAIL ADDRESS:
STREET 1: 317 UNIVERSITY AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DCVC Bio GP, LLC
CENTRAL INDEX KEY: 0001735070
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 211036588
BUSINESS ADDRESS:
STREET 1: 317 UNIVERSITY AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 415-840-7337
MAIL ADDRESS:
STREET 1: 317 UNIVERSITY AVENUE, SUITE 200
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JNK Capital Management, LLC
CENTRAL INDEX KEY: 0001836273
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 211036587
BUSINESS ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 415-840-7337
MAIL ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZNM Capital Management, LLC
CENTRAL INDEX KEY: 0001836103
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 211036586
BUSINESS ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
BUSINESS PHONE: 415-840-7337
MAIL ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stead Kiersten
CENTRAL INDEX KEY: 0001836117
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 211036584
MAIL ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bogue Zachary
CENTRAL INDEX KEY: 0001836157
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39781
FILM NUMBER: 211036585
MAIL ADDRESS:
STREET 1: 270 UNIVERSITY AVENUE
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AbCellera Biologics Inc.
CENTRAL INDEX KEY: 0001703057
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
BUSINESS PHONE: (604) 559-9005
MAIL ADDRESS:
STREET 1: 2215 YUKON STREET
CITY: VANCOUVER
STATE: A1
ZIP: V5Y 0A1
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-18
0
0001703057
AbCellera Biologics Inc.
ABCL
0001735069
DCVC Bio, L.P.
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001735070
DCVC Bio GP, LLC
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001836273
JNK Capital Management, LLC
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001836103
ZNM Capital Management, LLC
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001836157
Bogue Zachary
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001836089
Ocko Matthew
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
0001836117
Stead Kiersten
270 UNIVERSITY AVENUE
PALO ALTO
CA
94301
0
0
1
0
Common Shares
2021-06-18
4
J
0
5000000
0.00
D
24105761
I
See Footnote
Common Shares
2021-06-18
4
J
0
73892
0.00
A
73892
I
See Footnote
On June 18, 2021, DCVC Bio, L.P. ("DCVC Bio") distributed, for no consideration, an aggregate of 5,000,000 Common Shares of the Issuer ("DCVC Bio Shares") to its limited partners and to DCVC Bio GP, LLC ("DCVC Bio GP"), its general partner, representing each such partner's pro rata interest in such DCVC Bio Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.
These securities are held by DCVC Bio. DCVC Bio GP is the general partner of DCVC Bio and has sole voting and dispositive power with regard to the securities held by DCVC Bio. JNK Capital Management, LLC ("JNK") and ZNM Capital Management, LLC ("ZNM") are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio.
(Continued from Footnote 2) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any.
These securities are held by DCVC Bio GP. JNK and ZNM are the managing members of DCVC Bio GP and share voting and dispositive power with respect to the securities held by DCVC Bio GP. The managing members of JNK and ZNM are Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead. Matthew Ocko, Zachary Bogue, John Hamer and Kiersten Stead share voting and dispositive power with respect to the securities held by DCVC Bio GP.
(Continued from Footnote 4) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of such securities and this report shall not be deemed an admission that it is the beneficial owner of such securities, except to the extent of its indirect pecuniary interest therein, if any.
This is one of two Form 4s filed on the date hereof in respect of these securities. The Reporting Person for the other Form 4 is John Hamer.
DCVC Bio, L.P. By: DCVC Bio GP, LLC Its: General Partner By: ZNM Capital Management, LLC Its: Managing Member By: /s/ Matthew Ocko Matthew Ocko, Managing Member
2021-06-21
DCVC Bio GP, LLC, By: ZNM Capital Management, LLC Its: Managing Member By: /s/ Matthew Ocko Matthew Ocko, Managing Member
2021-06-21
JNK Capital Management, LLC, By: /s/ Kiersten Stead Kiersten Stead, Managing Member
2021-06-21
ZNM Capital Management, LLC By: /s/ Matthew Ocko Matthew Ocko, Managing Member
2021-06-21
Zachary Bogue /s/ Zachary Bogue
2021-06-21
Matthew Ocko /s/ Matthew Ocko
2021-06-21
Kiersten Stead /s/ Kiersten Stead
2021-06-21